{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T21:23:38Z","timestamp":1787952218786,"version":"build-2784847793"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1097\/bor.0000000000000221","type":"journal-article","created":{"date-parts":[[2015,9,10]],"date-time":"2015-09-10T07:21:01Z","timestamp":1441869661000},"page":"549-554","source":"Crossref","is-referenced-by-count":10,"title":["Scleroderma renal crisis"],"prefix":"10.1097","volume":"27","author":[{"given":"Marie","family":"Hudson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-6-20210128","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0002-9343(84)90986-0","article-title":"Factors predicting development of renal involvement in progressive systemic sclerosis.","volume":"76","author":"Steen","year":"1984","journal-title":"Am J Med"},{"key":"R3-6-20210128","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/ard.2006.062901","article-title":"Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database.","volume":"66","author":"Walker","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"R4-6-20210128","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.semarthrit.2013.09.008","article-title":"Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis-results from the International Scleroderma Renal Crisis Survey.","volume":"43","author":"Hudson","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"R6-6-20210128","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3899\/jrheum.130386","article-title":"Prevalence, correlates and outcomes of gastric antral vascular ectasia in systemic sclerosis: a EUSTAR case-control study.","volume":"41","author":"Ghrenassia","year":"2014","journal-title":"J Rheumatol"},{"key":"R7-6-20210128","first-page":"S1106","article-title":"Scleroderma renal crisis and pulmonary arterial hypertension are very rare in the same patient.","volume":"65","author":"Lynch","year":"2013","journal-title":"Arthritis Rheum"},{"key":"R9-6-20210128","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/qjmed\/hcm052","article-title":"Scleroderma renal crisis: patient characteristics and long-term outcomes.","volume":"100","author":"Penn","year":"2007","journal-title":"QJM"},{"issue":"suppl 1","key":"R10-6-20210128","doi-asserted-by":"crossref","first-page":"i179","DOI":"10.1093\/rheumatology\/keu127.017","article-title":"The prognosis of scleroderma renal crisis in RNA-polymerase III antibody-positive compared to RNA-polymerase III antibody-negative patients.","volume":"53","author":"Lynch","year":"2014","journal-title":"Rheumatology"},{"key":"R11-6-20210128","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.7326\/0003-4819-119-10-199311150-00007","article-title":"Autoantibody reactive with RNA polymerase III in systemic sclerosis.","volume":"119","author":"Okano","year":"1993","journal-title":"Ann Intern Med"},{"key":"R12-6-20210128","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1172\/JCI116343","article-title":"Autoantibody reactive with three classes of RNA polymerases in sera from patients with systemic sclerosis.","volume":"91","author":"Kuwana","year":"1993","journal-title":"J Clin Invest"},{"key":"R13-6-20210128","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/art.38994","article-title":"Clinical and immunologic predictors of scleroderma renal crisis in Japanese systemic sclerosis patients with anti-RNA polymerase III autoantibodies.","volume":"67","author":"Hamaguchi","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R16-6-20210128","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0889-857X(03)00016-4","article-title":"Scleroderma renal crisis.","volume":"29","author":"Steen","year":"2003","journal-title":"Rheumatic diseases clinics of North America"},{"key":"R17-6-20210128","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/art.30111","article-title":"HLA-DRB10407 and 1304 are risk factors for scleroderma renal crisis.","volume":"63","author":"Nguyen","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"suppl 1","key":"R18-6-20210128","first-page":"i159","article-title":"Defining genetic risk for scleroderma renal crisis: a genome-wide analysis of anti-RNA polymerase antibody-positive systemic sclerosis.","volume":"54","author":"Guerra","year":"2014","journal-title":"Rheumatology"},{"key":"R19-6-20210128","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1056\/NEJMra1312353","article-title":"Syndromes of thrombotic microangiopathy.","volume":"371","author":"George","year":"2014","journal-title":"N Engl J Med"},{"key":"R20-6-20210128","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.humpath.2008.08.001","article-title":"Renal biopsy findings predicting outcome in scleroderma renal crisis.","volume":"40","author":"Batal","year":"2009","journal-title":"Hum Pathol"},{"issue":"suppl 1","key":"R22-6-20210128","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/rheumatology\/keu127.009","article-title":"Perturbed response to experimental renal injury in a mouse model of systemic sclerosis.","volume":"53","author":"Derrett-Smith","year":"2014","journal-title":"Rheumatology"},{"key":"R23-6-20210128","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatologyEuropean league against rheumatism collaborative initiative.","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"R25-6-20210128","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/qjmed\/hct111","article-title":"Targeting the endothelin axis in scleroderma renal crisis: rationale and feasibility.","volume":"106","author":"Penn","year":"2013","journal-title":"QJM"},{"key":"R26-6-20210128","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s100670050132","article-title":"Immunohistological study endothelin-1 and endothelin-A and B receptors in two patients with scleroderma renal crisis.","volume":"18","author":"Kobayashi","year":"1999","journal-title":"Clin Rheumatol"},{"key":"R27-6-20210128","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.humpath.2010.05.018","article-title":"Endothelin-1 expression in scleroderma renal crisis.","volume":"42","author":"Mouthon","year":"2011","journal-title":"Hum Pathol"},{"key":"R28-6-20210128","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.ajkd.2009.02.015","article-title":"Endothelin receptor antagonism and renin inhibition as treatment options for scleroderma kidney.","volume":"54","author":"Dhaun","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"R29-6-20210128","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.berh.2004.03.001","article-title":"Scleroderma - clinical and pathological advances.","volume":"18","author":"Denton","year":"2004","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R30-6-20210128","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/ard.2006.066985","article-title":"Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients.","volume":"67","author":"Teixeira","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"R31-6-20210128","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1097\/BOR.0b013e3283108df7","article-title":"Diagnosis, management and prevention of scleroderma renal disease.","volume":"20","author":"Penn","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"R33-6-20210128","first-page":"2716","article-title":"Development of a Renal Crisis Prevention Card As an educational tool aimed at improving outcomes in high-risk patients with systemic sclerosis.","volume":"66","author":"Shapiro","year":"2014","journal-title":"Arthritis Rheumatol"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/BOR.0000000000000221","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:37:36Z","timestamp":1786048656000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002281-201511000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000221","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]}}}